Secure Transfusion Services, Inc. (“STS”) is an emerging growth life sciences company focused on improving the quality and availability of transfusable blood components. Emphasizing donor and patient safety and employing best practices in operational excellence, our goal is to modernize the transfusion medicine supply chain. STS develops and operates donor-friendly, free-standing blood collection sites, located near its customers, typically large medical centers engaged in complex patient care, creating the opportunity for best-in-class service.
Launched in 2018, STS completed its Series A financing in February 2019, which included investments from its strategic partners, OneBlood and Cerus Corporation. Our company is currently building out its flagship collection sites and establishing its strategic anchor customers.